Share Name Share Symbol Market Type Share ISIN Share Description
Synthomer Plc LSE:SYNT London Ordinary Share GB0009887422 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -2.20 -0.98% 222.80 1,658,732 16:35:19
Bid Price Offer Price High Price Low Price Open Price
222.40 222.60 228.60 220.00 220.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Chemicals 2,329.50 283.90 48.30 4.6 1,041
Last Trade Time Trade Type Trade Size Trade Price Currency
17:58:28 O 3,795 226.676 GBX

Synthomer (SYNT) Latest News (3)

More Synthomer News
Synthomer Investors    Synthomer Takeover Rumours

Synthomer (SYNT) Discussions and Chat

Synthomer Forums and Chat

Date Time Title Posts
07/8/201819:23Synthomer (SYNT) One to Watch on Monday 1

Add a New Thread

Synthomer (SYNT) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Synthomer trades in real-time

Synthomer (SYNT) Top Chat Posts

Synthomer Daily Update: Synthomer Plc is listed in the Chemicals sector of the London Stock Exchange with ticker SYNT. The last closing price for Synthomer was 225p.
Synthomer Plc has a 4 week average price of 218.20p and a 12 week average price of 218.20p.
The 1 year high share price is 570.50p while the 1 year low share price is currently 218.20p.
There are currently 467,336,041 shares in issue and the average daily traded volume is 1,225,563 shares. The market capitalisation of Synthomer Plc is £1,041,224,699.35.
gstarkey: Analysts’ consensus eps forecast for calendar 2022 is 29p, so on a 40% payout ratio, that’s a full year forecast dividend of 11-12p. Quality company with share price currently very low in the water but sadly lots of others out there.
turvart: One thing that there is a trend is the price of chemicals follow in most cases the price of oil and SYNT will just increase profit pro-rata, I just can't wait to read the interim accounts because I think we are sat on a £5 possible £6 share price here, it's always hard to picture when the share price is here.
turvart: Hi spangle93, You ask my opinion on what you call the "disconnect". This is my opinion: In last years 2021 results SYNT have exceptional results across the board of products, however they had a fantastic uplift in latex glove sales up 136% due to covid 19 sales and they state in the results that sales should go back to 2019 levels before the pandemic. So what we have had IMO is the share price well over £5 due to these latex sales and massive emphasis have been put on these latex sales rather than people actually spending time to read the accounts and see that the whole range of products was actually up by a very good margin also. Another reason also is the fact again that some people don't understand how to read accounts and feel that SYNT are massively in debt because of the Eastman's Resin acquisition, quite simply it's not, they used their profit, had a share placing and used a 300 Mln credit facility to finance it of which they did comfortable and if people understand accounts will realise that after the takeover SYNT current assets are far higher than current liabilities. Another area is that people are second guessing and sticking their finger in the air stating that the dividend is going to be cut, this is another area that I strongly disagree and I feel the dividend will actually be higher based on my projection that EPS figures will be higher due to the recent acquistions and the BOD state that 40% of EPS will be paid minimum in dividends. Fortunately for me I do fully understand how to read accounts and I have been investing for well over 21 years and know a good stock when I see one and SYNT will deliver the EPS and this is what does the real talking in fundamentals. I hope this helps. Regards, Turvart.
montyhedge: They could be stakebuilding. Hopefully they don't bid, we want our juicy dividends to continue. Synt go ex div 5th June, payable 5th July, dividend 21.30p. Perhaps they are thinking get the massive dividend, make a bid afterwards, I hope not, sure Synt has a lot of potential. Nice to see a non ex director bought shares at 308p yesterday. I think with all the interest coming in, I rrckon 350p before ex div.
turvart: I think what people seem to forget with stocks like SYNT is the company will or should capitalize on the rising oil price, oil prices filter through to the chemical industry and prices WILL rise, this won't show though until probably the interim results. For SYNT to be trading at £3 share price is just incredible, it's certainly in my portfolio.
elsa7878: I have a few shares but think the share price would be higher if they prioritised debt repayments over dividends.
kenmitch: The next dividend around 21p gives a near 7% yield just for that one dividend. Agree that it’s likely to be cut but the attraction is also a good chance of a 30% or more share price bounce from what looks an oversold level. And there were rumours and Press comment about a bid a while ago, and a bid can’t be ruled out either.
brucie5: Nice to see you guys here - I usually expect to be following your lead. ;) Featured in the IC today under Nine high Yield Low Risk Stocks. I won't paste anything further, though I hardly expect the share price to shoot up. But reassured to see the emphasis on 'low risk', though this does not apparently include geographical risk as FXPO included as, unsurprisingly, the highest yielder. Beneath which, RIO, then SYNT. As to dividend, it gives historic 9.8 falling to 5.6 over next 12 months.
tole: second share I would consider is aqueous polymers specialist Synthomer (LSE: SYNT). The company's latest annual dividend means that it is currently offering an eye-watering yield of 9.8%. The 30p per share dividend was comfortably covered by basic earnings per share that came in at 75.2p.With its strong position in an important part of many commercial production chains, Synthomer has been doing well thanks to strong demand. I am concerned, though, that cost inflation could damage profit margins over the next couple of years. Additionally, Nitrile latex demand is now subdued after previous stockpiling of items such as medical gloves. That could lead to revenues falling.Shares to buy now for my portfolioBut I see such ups and downs of the demand cycle as an inevitable part of life for a basic materials producer like Synthomer. In the long term I expect demand for its products to remain substantial. That should help support profits.The dividend jump last year reflected a pandemic-era demand surge. So I do not expect such a high payout in future. The company called the dividend raise an "exceptional increase reflecting the unique year of profitability". But I still hope the company can still pay attractive dividends in future, even if at a lower level.The price-to-earnings ratio is currently around seven. That valuation looks cheap to me, although if earnings fall next year the prospective P/E ratio would be higher. From a buy and hold perspective, I would be happy to add these shares to my portfolio.
km18: ...from last year... Company overview: Synthomer is a specialist chemical company and one of the world’s foremost suppliers of polymers. Headquartered in London, the company operates globally through more than 4000 employees across 38 sites. The company’s diversified portfolio of products serves customers in various sectors, such as adhesives, construction, textiles, energy, paper, coatings etc. In April last year they acquired OMNOVA solutions, a US based specialty chemical company. The transaction resulted in a global specialty chemicals specialty with significant scale. SYNT’s biggest benefit is probably  the material strength on the US market combined with penetration of the Chinese market, from the acquisition. Growth is following a blended approach with several acquisitions over the last decade and constant investments in innovation. This is confirmed by the 20% of revenue arriving from products less than five years old. The company’s portfolio provides a diversified exposure to various sectors, such as Health & Protection, Carpets, Paper, Adhesives, coating, Oil & Gas etc. Performance Elastomers and Functional solutions (OMNOVA CAST is dealing in the latter) brought around 80% of the revenue in 2020 with a total of $1.327bn. Markets where the Group operates are growing consistently and the acquisition of OMNOVA generated $30m of synergy savings run rate achieved by the end of 2020. The year saw record EBITDA at £259.4 million (45.8% growth) with 14% CAGR over the period 2014-2020. Latest interim updated delivered sky high figures driven by strong demand for nitrile products, which are used in PPE for healthcare providers. The strong performance is based on the fact that the Group was part of an essential industry very early on in the pandemic, meaning their sites ran uninterrupted. The Performance Elastomers quadrupled cash profits and operational gearing went into overdrive. Working capital was affected by inflation in prices, but the demand outbalanced the price impact and kept WC/Total sales at 10%. The only thing which weakens the view is the impairment of £22.5m, but hey, we always said – if you are pursuing a growth through acquisitions strategy, brace yourself, as the fair value is rarely achieved in these transactions. Management expects normalized demand in Q3. Following the recent impairments, the outlook for these looks stress free, but we will monitor it closely as the intangibles account for £839m of the assets. Short analysis: Cash went up by 36%, from strong performance Net debt positive as cash did not cover debt levels CA/CL =  1.6 Cash ratio = 0.50 Interest coverage (FY 2020) = P/S TTM= 1.08, which is way better than industry average BV ps TTM = 190, growing at 16.1% CAGR Operating profit for the interim was £288.6m, 4 times more than H1 2020... ...from WealthOracleAM
Synthomer share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220702 16:53:31